ATE329580T1 - Einbau aktiver substanzen in trägermatrizen - Google Patents

Einbau aktiver substanzen in trägermatrizen

Info

Publication number
ATE329580T1
ATE329580T1 AT99924076T AT99924076T ATE329580T1 AT E329580 T1 ATE329580 T1 AT E329580T1 AT 99924076 T AT99924076 T AT 99924076T AT 99924076 T AT99924076 T AT 99924076T AT E329580 T1 ATE329580 T1 AT E329580T1
Authority
AT
Austria
Prior art keywords
installation
active substances
carrier matrices
matrices
carrier
Prior art date
Application number
AT99924076T
Other languages
English (en)
Inventor
Marie-Louise Andersson
Catherine Boissier
Anne Marie Juppo
Anette Larsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE329580T1 publication Critical patent/ATE329580T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Nozzles (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT99924076T 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen ATE329580T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Publications (1)

Publication Number Publication Date
ATE329580T1 true ATE329580T1 (de) 2006-07-15

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924076T ATE329580T1 (de) 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen

Country Status (31)

Country Link
US (1) US6372260B1 (de)
EP (1) EP1069890B1 (de)
JP (1) JP2002511400A (de)
KR (1) KR100600691B1 (de)
CN (1) CN1201728C (de)
AR (1) AR019262A1 (de)
AT (1) ATE329580T1 (de)
AU (1) AU744874B2 (de)
BR (1) BR9909636A (de)
CA (1) CA2327522C (de)
CY (1) CY1105154T1 (de)
CZ (1) CZ20003784A3 (de)
DE (1) DE69931904T2 (de)
DK (1) DK1069890T3 (de)
EE (1) EE200000595A (de)
ES (1) ES2267268T3 (de)
HU (1) HUP0102305A3 (de)
ID (1) ID29286A (de)
IL (1) IL138635A0 (de)
IS (1) IS5656A (de)
NO (1) NO329145B1 (de)
NZ (1) NZ507190A (de)
PL (1) PL344077A1 (de)
PT (1) PT1069890E (de)
RU (1) RU2208435C2 (de)
SE (1) SE9801287D0 (de)
SK (1) SK14112000A3 (de)
TR (1) TR200002960T2 (de)
TW (1) TW542724B (de)
WO (1) WO1999052507A1 (de)
ZA (1) ZA992549B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045731A1 (en) * 1999-12-21 2001-06-28 Rxkinetix, Inc. Particulate drug-containing products and method of manufacture
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
PT1429802E (pt) * 2001-09-28 2013-01-24 Tntgamble Inc Sistema de entrega para componente biológico
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) * 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
ES2312996T3 (es) * 2003-04-29 2009-03-01 N.V. Organon Proceso de solidificacion con antidisolvente.
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
GB2401547B (en) 2003-05-08 2005-07-20 Nektar Therapeutics Uk Ltd Particulate materials
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080095856A1 (en) * 2006-05-12 2008-04-24 Jacobson Gunilla B Encapsulated Nanoparticles for Drug Delivery
FR2900845B1 (fr) * 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (de) 2006-10-19 2008-04-23 Gerhard, Markus Neue Methode zur Behandlung von Infektionen durch H. pylori
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (de) 2016-07-20 2018-01-24 Technische Universität München Wirkstoffe und verfahren zur vorbeugung oder behandlung von h.-pylori-infektionen
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
CZ20003784A3 (cs) 2001-08-15
AU4066399A (en) 1999-11-01
HUP0102305A3 (en) 2003-04-28
CN1201728C (zh) 2005-05-18
PT1069890E (pt) 2006-09-29
BR9909636A (pt) 2000-12-19
CY1105154T1 (el) 2010-03-03
HUP0102305A2 (hu) 2001-12-28
DE69931904D1 (de) 2006-07-27
EP1069890B1 (de) 2006-06-14
RU2208435C2 (ru) 2003-07-20
CN1309555A (zh) 2001-08-22
IS5656A (is) 2000-10-11
ES2267268T3 (es) 2007-03-01
JP2002511400A (ja) 2002-04-16
PL344077A1 (en) 2001-09-24
SE9801287D0 (sv) 1998-04-14
NO20005150L (no) 2000-12-08
DE69931904T2 (de) 2006-12-21
NZ507190A (en) 2002-02-01
KR100600691B1 (ko) 2006-07-19
NO329145B1 (no) 2010-08-30
TW542724B (en) 2003-07-21
WO1999052507A1 (en) 1999-10-21
KR20010042660A (ko) 2001-05-25
ID29286A (id) 2001-08-16
EE200000595A (et) 2002-04-15
DK1069890T3 (da) 2006-08-28
AR019262A1 (es) 2002-02-13
IL138635A0 (en) 2001-10-31
TR200002960T2 (tr) 2000-12-21
CA2327522A1 (en) 1999-10-21
ZA992549B (en) 1999-10-14
US6372260B1 (en) 2002-04-16
EP1069890A1 (de) 2001-01-24
AU744874B2 (en) 2002-03-07
CA2327522C (en) 2008-03-25
SK14112000A3 (sk) 2001-07-10
NO20005150D0 (no) 2000-10-13

Similar Documents

Publication Publication Date Title
DE69931904D1 (de) Einbau aktiver substanzen in trägermatrizen
DE69942411D1 (de) Verankerungsplattenmodul
ID24106A (id) Instalasi dehidrasi
DK0920873T3 (da) Stabiliserede teriparatidoplösninger
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
DE69729328D1 (de) Mikrostrukturiertes polymersubstrat
DE69841511D1 (de) Halbleiter
FR2765563B1 (fr) Support de pastilles semi-conductrices
DE69909555D1 (de) Verteiltes Anrufsystem
DE69815524D1 (de) Haftende mikrokapseln enthaltend biologisch aktive substanzen
NO996040D0 (no) Jordtestings-montasje
DK1068139T3 (da) Transportørunderlag
ATE189440T1 (de) Eiertragplatte
DE69807695T2 (de) Eprosartan-monohydrate
DE69841156D1 (de) Halbleiter
DE29803417U1 (de) Kreuzstützbandage
FR2777040B1 (fr) Structure catalytiquement active
DE29808529U1 (de) Installationsmodul
DE29711623U1 (de) Photovoltaik-Anlage
DE29821009U1 (de) Trägermischstruktur
DE29814819U1 (de) Rahmenartiger Träger
DE29803952U1 (de) Träger
DE29720014U1 (de) Installationsvorrichtung
DE29708618U1 (de) Gärgutträger
DE29712629U1 (de) Pflanzsubstrat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1069890

Country of ref document: EP

REN Ceased due to non-payment of the annual fee